glp-1 agonists drug class receptor Are Serious Anesthesia Risks of

So GLP-1 arent first-line for HF, but they dont harm and do help weight, which is useful

81401852), the Natural Science Foundation of Shanghai (No

Injectables: GLP-1 and GIP/GLP-1 RAs versus basal insulin Randomised controlled trials (RTCs) have demonstrated that both semaglutide (Aroda et al, 2017) and tirzepatide (Ludvik et al, 2021

In January 2025, Novo Nordisk disclosed key findings from the STEP UP study , a Phase IIIb trial within the global STEP program

Hospital pharmacies typically dominate the distribution of injectable GLP-1 therapies, while retail pharmacies are more suited for oral formulations

Retatrutide is still not FDA-approved, so patients should not use it outside clinical trials